Current Research in Drug Discovery
About the Journal
Aims and Scope
Current Research in Drug Discovery is a peer-reviewed open access journal that publishes original research papers and review articles on drug discovery and development. Focused on small molecules, specific areas of interest include screening technologies, target and lead identification and validation, laboratory automation, high throughput screening, assay development and validation, high content analysis, data mining, biomarkers discovery, ADME, BioMEMS, microfluidics, sample management, biobanking, cell based assay, 3D cell culture, phenotypic screening. We strongly encourage young researchers to submit their original works.
Current Research in Drug Discovery is a gold open access publication which means that all published manuscripts are feely available for unlimited access.
Open access publishing provides immediate, worldwide free access to all published manuscripts. Readers can view, download, print, and redistribute any article without any financial barrier, enabling greater distribution of an article.
Once published, the article will be made free to read and reuse upon publication under a Creative Commons Attribution (CC-BY) licence.
The publication costs of an article are paid from an author's research budget, or by their supporting institution. These Article Processing Charges replace subscription charges covers the costs of manuscript processing, online availability, hosting and archiving.
All Science Publication’s journals adhere to the open access policy. Once our highly qualified Editorial Board has accepted the manuscript, authors will receive an invoice including the publication charges for their manuscript.
Abstracting and Indexing
All articles published in Current Research in Drug Discovery are included in: